000 05738cam a2200433Mi 4500
001 95004
003 ES-MaUEC
005 20230102112642.0
006 m o d
007 cr |n|||||||||
008 161207s2017 sz ob 001 0 eng d
020 _a3319460889
_q(electronic bk.)
020 _a9783319460888
_q(electronic bk.)
020 _z3319460870
020 _z9783319460871
035 _a(OCoLC)965518662
_z(OCoLC)965375113
_z(OCoLC)965736355
_z(OCoLC)974651559
040 _aYDX
_cYDX
_dN$T
_dEBLCP
_dIDEBK
_dGW5XE
_dN$T
_dIDB
_dUAB
_dCOO
_dOCLCQ
_dIOG
_dESU
_dJBG
_dIAD
_dICW
_dICN
_dOTZ
_dOCLCQ
_dUPM
_dVT2
_dOCLCF
_dMERER
_dOCLCQ
_dU3W
_dMERUC
_dES-MaUEC
_bspa
050 4 _aRC469
_b.G847 2017 EB
100 1 _aGuest, Paul C.
245 1 0 _aBiomarkers and mental illness :
_bits not all in the mind
_cPaul C. Guest.
264 1 _aCham, Switzerland
_bCopernicus is a brand of Springer
_c2017
300 _a1 recurso en línea
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
500 _aSpringerLink
_bSpringer Biomedical and Life Sciences eBooks 2017 English+International
504 _aIncluye referencias bibliográficas e índice
505 0 _aPreface; Contents; Part I: A Brief History of Biomarkers and Mental Illness; Chapter 1: Psychiatric Disorders as "Whole Body" Diseases; A Brief History of Psychiatric Disease: The Curse of the Gods?; Is It All in the Blood or Other Body Fluids?; What Went Wrong in the Middle Ages?; Phase 1; Phase 2; Phase 3; Phase 4; Famous People with Psychiatric Disorders; Is It All in the Mind?; The Basics: Neurotransmission; The Disconnectivity Theory of Mental Disorders; What Can We Learn About Brain Function by Studying the Serum?
505 8 _aChapter 2: Treatment of€Psychiatric Disorders: Time for€a€Paradigm Change? What Is the€Clinical Need?; What Is a€Biomarker?; Clinical Examples; Case 1; Case 2; Case 3; Case 4; Current Diagnostic Practices in€Psychiatry; How Might Biomarkers Be€Used in€Psychiatry?; As an€Aid to€Diagnosis; Identification of€Diagnostic Subgroups; Treatment Response Prediction; Helping to€Redefine the€Diagnostic Categories; Helping to€Identify Staging of€Psychiatric Diseases; What Kinds of€Biomarkers Have Been Identified?; Future Prospects.
505 8 _aChapter 3: The Importance of€Biomarkers: The€Required Tools of€the€Trade Why Do We€Need Biomarkers in€Psychiatry?; Proteomics; What Are the€Main Biomarker Technologies?; Mulitplex Immunoassay; Two-Dimensional Gel Electrophoresis; Mass Spectrometry; 1H-Nuclear Magnetic Resonance (NMR) Spectroscopy; Imaging Techniques; Future Prospects; Part II: Psychiatric Diseases ; Chapter 4: Schizophrenia and€the€Mind-Body Connection; How Do We€Currently Diagnose Schizophrenia?; Can This Be€Improved By Incorporation of€Biomarkers?; Schizophrenia Symptoms; Positive Symptoms; Negative Symptoms.
505 8 _aCognitive Symptoms Diagnostic Tools; DSM; Positive and Negative Syndrome Scale (PANSS); Brain Effects; Neurotransmitter Theories of Schizophrenia; Dopamine; Glutamate; GABA; Acetylcholine; Serotonin; The Link Between the Brain and the Periphery; Are There Any Novel Treatments on the Horizon?; Can We Improve Treatment Response of Patients Using Biomarkers?; Development of Biomarker Tests to Detect Schizophrenia Before Disease Onset; Future Prospects in Schizophrenia Research; Chapter 5: Progress for Better Treatment of Depression; Why Is It Difficult to Diagnose Depression?
505 8 _aDiagnostic Tools DSM-5; Hamilton Depression Rating Scale (HAM-D); Why Is It So€Difficult to€Treat Depression?; What Is Going on€in€the€Brains of€Depressed Patients and€Why Does It Take Antidepressants So€Long to€Work?; Can We€Detect Depression Using Biomarkers in€the€Blood?; Stress Hormones; Other Hormones; Growth Factors; Inflammation; Oxidative Stress; Can We€Develop a€Blood Test for€Major Depressive Disorder?; Are There Any Novel Treatments on€the€Horizon for€Depression?; Future Prospects in€Depression Research; Chapter 6: The Special Case of€Bipolar Disorder.
520 3 _aEmploying accessible language throughout, this book covers the history of psychiatric research, the current state-of-the art in psychiatric practice, the physiological systems affected by psychiatric illnesses, the whole-body nature of these diseases and the impact that this aspect has on emerging biomarker discoveries. Further, it provides descriptions of the major specific psychiatric disorders and the special challenges regarding the diagnosis and treatment of each. The book concludes with insights into the latest developments in hand-held biomarker test devices, which can provide diagnostic information in less than 15 minutes in point-of-care settings. This book investigates the emerging use of biomarkers in the study of psychiatric diseases, a topic of considerable importance for a broad range of people including researchers, clinicians, psychiatrists, university students and even those whose lives are affected in some way by a psychiatric illness. The last category is hardly trivial, since a staggering one in three people worldwide show the criteria for at least one psychiatric disorder at some point in their lifetime. .
650 7 _aPsiquiatría
_2embne
_0(OCoLC)fst01081152
_0
_9139041
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-46088-8
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aEBOOK, asignarmaterias, EBSPRINGER_2017B
998 _b02/2018
_dz
_e-
_zSI
999 _c95004
_d95004
_x1